类风湿关节炎的死亡率估计与超额死亡率
研究基于澳大利亚风湿病协会数据库(ARAD)中1995年后确诊的1895例类风湿关节炎患者,通过链接国家死亡索引获取死亡数据,并与年龄、性别和日历年匹配的澳大利亚人群死亡率比较。随访20年时标准化死亡比(SMR)为1.49(95%CI 1.30, 1.71),相对生存率为94%(95%CI 91, 97),20年限制性平均生存时间(RMST)观察值18.41年与期望值18.68年相差4个月;呼吸系统疾病(肺炎CS-SMR 5.2,间质性肺病CS-SMR 7.6)是重要根本死因,而冠心病和肿瘤的CS-SMR未显著升高。
要点
- 随访前10年死亡率未见增加,20年时SMR为1.49(95%CI 1.30, 1.71)。
- 20年相对生存率为94%(95%CI 91, 97),RMST观察值18.41年 vs 期望值18.68年,相差4个月。
- 呼吸系统疾病是重要根本死因,肺炎CS-SMR 5.2(95%CI 2.3, 10.3),间质性肺病CS-SMR 7.6(95%CI 3.0, 14.7)。
核心结论
- 该RA队列的死亡风险随时间累积,随访20年时中度增加。
- 呼吸系统疾病可能已取代心血管疾病成为这一死亡率差距的主要贡献因素。
研究设计与样本
- 纳入澳大利亚风湿病协会数据库(ARAD)中1995年后确诊且同意数据链接的RA患者。
- 通过链接澳大利亚国家死亡索引获取死亡数据,并与年龄、性别和日历年匹配的澳大利亚人群死亡率比较。
- 分析包括标准化死亡比(SMR)和相对生存模型,计算20年限制性平均生存时间(RMST)作为生命损失度量,并按ICD-10死因分类估计死因别SMR(CS-SMR)。
主要发现
- 共纳入1895例RA患者,74%为女性,基线中位年龄50岁(四分位距41-58),发生204例死亡。
- 随访前10年死亡率未见增加,20年时SMR为1.49(95%CI 1.30, 1.71),相对生存率为94%(95%CI 91, 97)。
- 20年RMST观察值为18.41年,期望值为18.68年,相差4个月。
- 呼吸系统疾病是重要根本死因,主要归因于肺炎[CS-SMR 5.2(95%CI 2.3, 10.3)]和间质性肺病[CS-SMR 7.6(95%CI 3.0, 14.7)]。
- 冠心病[CS-SMR 0.82(95%CI 0.42, 1.4)]和肿瘤[CS-SMR 1.2(95%CI 0.89, 1.5)]的CS-SMR未显著升高。
临床怎么用
- 原文未据此给出推荐,结论指出该RA队列死亡风险随时间累积、20年时中度增加,呼吸系统疾病可能已取代心血管疾病成为死亡率差距的主要贡献因素。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
OBJECTIVES: To determine long-term (20 year) survival in RA patients enrolled in the Australian Rheumatology Association Database (ARAD). METHODS: ARAD patients with RA and data linkage consent who were diagnosed from 1995 onwards were included. Death data were obtained through linkage to the Australian National Death Index. Results were compared with age-, gender- and calendar year-matched Australian population mortality rates. Analysis included both the standardized mortality ratio (SMR) and relative survival models. Restricted mean survival time (RMST) at 20 years was calculated as a measure of life lost. Cause-specific SMRs (CS-SMRs) were estimated for International Classification of Diseases, Tenth Revision cause of death classifications. RESULTS: A total of 1895 RA patients were included; 74% were female, baseline median age 50 years (interquartile range 41-58), with 204 deaths. There was no increase in mortality over the first 10 years of follow up, but at 20 years the SMR was 1.49 (95% CI 1.30, 1.71) and the relative survival was 94% (95% CI 91, 97). The difference between observed (18.41 years) and expected (18.68 years) RMST was 4 months. Respiratory conditions were an important underlying cause of death in RA, primarily attributable to pneumonia [CS-SMR 5.2 (95% CI 2.3, 10.3)] and interstitial lung disease [CS-SMR 7.6 (95% CI 3.0, 14.7)], however, coronary heart disease [CS-SMR 0.82 (95% CI 0.42, 1.4)] and neoplasms [CS-SMR 1.2 (95% CI 0.89, 1.5)] were not. CONCLUSION: Mortality risk in this RA cohort accrues over time and is moderately increased at 20 years of follow-up. Respiratory diseases may have supplanted cardiovascular diseases as a major contributor to this mortality gap.
引用
- Black RJ, Lester S, Tieu J, et al. Mortality estimates and excess mortality in rheumatoid arthritis. Rheumatology (Oxford). 2023. PMID: 36919770. doi:10.1093/rheumatology/kead106
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。